ALAMYCIN*AEROSOL*SPRAY 5G/140G CAN AEROSOL SPRAY

Indications

• Asthma
• Chronic obstructive pulmonary disease (COPD)
• Bronchospasm
• Allergic rhinitis
• Cystic fibrosis

Dosage

Children: Refer to specific aerosol medication guidelines for paediatric dosing, as it varies based on the active ingredient and age

Adults: Refer to specific aerosol medication guidelines for dosing details, as it varies widely depending on the active ingredient and condition being treated.

Mechanism of action

The mechanism of action for aerosolized medications varies depending on the specific drug used. For bronchodilators, they typically act by stimulating beta-2 adrenergic receptors in the bronchial smooth muscle, leading to relaxation and dilation of the airways. Corticosteroids, when delivered via aerosol, work by reducing inflammation and mucus production in the airways, thus improving airflow and reducing symptoms.

Pharmacodynamics

The pharmacodynamics of aerosolized medications involves their interaction with specific receptors in the respiratory tract. For example, beta-agonists lead to bronchodilation, which is characterized by decreased airway resistance and improved airflow. Corticosteroids exert anti-inflammatory effects, which contribute to the reduction of exacerbations and improvement in lung function over time. The onset of action for aerosolized medications is typically rapid, especially for short-acting bronchodilators, with peak effects occurring within minutes.

Pharmacokinetics

Aerosolized medications exhibit distinct pharmacokinetics due to their delivery method. The absorption occurs primarily in the lungs, where the drug can enter systemic circulation. The distribution can be localized to the lungs or systemic depending on the drug's properties and the size of the aerosol particles. Metabolism may occur in the liver or lungs, and elimination typically follows renal excretion. The half-life varies based on the specific medication used in aerosol form.

Adverse effects

• Cough
• Wheezing
• Throat irritation
• Nausea
• Headache

Precautions

• Use with caution in patients with asthma or other respiratory conditions
• Monitor for respiratory distress during use
• Ensure proper technique to avoid improper dosing

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and the benefits outweigh the risks.

Breast-feeding

Consult a healthcare provider before use. It's not known if aerosolized drugs pass into breast milk.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Metered-dose inhalers
• Nebulizer solutions
• Dry powder inhalers

Indications

• Bacterial infections (e.g. Chlamydia, Rickettsia, Mycoplasma)
• Acne
• Prophylaxis of asymptomatic meningococcal carrier state (not recommended)

Dosage

Adults: For adult patients, the typical dosage of oxytetracycline for susceptible infections is 100 mg twice daily for 5 days. For other conditions, such as acne, the dosage may be 500 mg twice daily, usually for a duration of 6 to 12 weeks, with the possibility of repeating the course intermittently.

Mechanism of action

Oxytetracycline exerts its antibacterial effects by binding to the 30S ribosomal subunit of bacteria, inhibiting the binding of aminoacyl-tRNA to the mRNA-ribosome complex. This action prevents the synthesis of proteins essential for bacterial growth and replication, leading to the bacteriostatic effect of the drug.

Pharmacodynamics

The pharmacodynamics of oxytetracycline involve its ability to inhibit bacterial protein synthesis, which is critical for the growth and reproduction of bacteria. The drug demonstrates a broad spectrum of activity against both Gram-positive and Gram-negative organisms, as well as some atypical pathogens. Its effectiveness can be influenced by the presence of tetracycline resistance mechanisms in certain bacterial strains.

Pharmacokinetics

Oxytetracycline is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 1-2 hours after oral administration. It has a relatively long half-life of about 8-10 hours, allowing for twice-daily dosing. The drug is widely distributed in body tissues and fluids, including the liver, kidneys, and lungs, but is less effective in central nervous system infections due to limited penetration. It is primarily excreted via urine, and dosage adjustments may be necessary in patients with renal impairment.

Contra-indications

• Children under 12 years due to deposition in growing bone and teeth, causing staining and occasionally dental hypoplasia

Adverse effects

• Gastrointestinal disturbances
• Photosensitivity
• Dental discoloration
• Hepatotoxicity
• Renal impairment
• Skin reactions including rash and urticaria
• Ataxia
• Hearing impairment
• Colitis
• Systemic lupus erythematosus exacerbation

Interactions

• Antacids and supplements containing calcium, magnesium, or iron may reduce absorption
• Oral contraceptives may be less effective
• Other tetracyclines
• Warfarin (may increase anticoagulant effect)

Precautions

• Use with caution in patients with renal impairment
• Monitor for hepatic toxicity in long-term use
• Patients should be advised to avoid excessive sunlight exposure
• Discontinue if systemic lupus erythematosus develops or worsens

Pregnancy

Oxytetracycline is contraindicated during pregnancy due to potential harm to fetal development, particularly affecting bone and dental health.

Breast-feeding

Use with caution; oxytetracycline is excreted in breast milk and may affect the infant's dental health.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oxytetracycline 250 mg tablets
• Oxytetracycline oral suspension
• Oxytetracycline oral solution